Pharmacoeconomics of Antibacterial Treatment

@article{Davey1992PharmacoeconomicsOA,
  title={Pharmacoeconomics of Antibacterial Treatment},
  author={Peter Garnet Davey and Mo M. Malek and Sharon E. Parker},
  journal={PharmacoEconomics},
  year={1992},
  volume={1},
  pages={409-437}
}
Antibacterial drugs account for between 3 and 25% of all prescriptions, between 6 and 21 % of the total market value of drugs in a single country, and up to 50% of the drug budget in hospitals. Bacterial infection is widely perceived as disease caused by harmful outside agents which can be isolated and tested to select the best drug for treatment. In fact, the need for any treatment and the pros and cons of different drugs are just as debatable as in any other therapeutic area. Moreover, the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 210 references

A cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers' diarrhea

  • RR Reves, PC Johnson, CD Ericcson, HL. DuPont
  • Archives ofInternal Medicine
  • 1988
Highly Influential
5 Excerpts

A comparison of the costs of ceftazidime therapy and gentamicin combinations in three UK hospitals

  • M Malek, W Lynch, N WeIls, T Elliott, A Bint
  • Journal of Antimicrobial Chemotherapy
  • 1992

Controversial issues in the management of urinary tract infections

  • SJ Gluckman, MJ DiNubile
  • Current Opinions in Infectious Disease
  • 1992

Similar Papers

Loading similar papers…